The steady revenue continued at the Interims with £1.7m generated by the established DXS SMART Referrals services, which is 2.2% ahead comparatively. It operated slightly better than break-even, which included however a £170k grant and £60k tax credit against at £121,567 loss. After prolonged investment in ExpertCare, the Hypertension medicine review service made a commercial sale in October 2024, and it is hoped it can be adapted for wider adoption. Along with continued R&D expenditure, ma ....
